Rh (RH) EBIT (2011 - 2026)

Rh has reported EBIT for 16 years, with the latest figure at $34.2 million in Q2 2026.

• On a quarterly basis, EBIT fell 38.75% year-over-year to $34.2 million in Q2 2026; TTM through May 2026 was $365.6 million, a 12.9% increase from a year earlier, with the FY2026 full-year figure at $387.3 million, up 20.05% from the prior year.
• EBIT was $34.2 million for Q2 2026 at Rh, down from $96.6 million in the prior quarter.
• The five-year high for EBIT was $234.4 million in Q3 2022, with the low at $34.2 million in Q2 2026.
• Average EBIT over 5 years is $113.9 million, with a median of $100.4 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: EBIT slumped 69.91% in 2023, then jumped 98.04% in 2024.
• Over 5 years, EBIT stood at $170.2 million in 2022, then plunged by 69.91% to $51.2 million in 2023, then jumped by 98.04% to $101.5 million in 2024, then grew by 4.4% to $105.9 million in 2025, then plunged by 67.67% to $34.2 million in 2026.
• The last three EBIT figures came in at $34.2 million (Q2 2026), $96.6 million (Q1 2026), and $105.9 million (Q4 2025), per Business Quant data.